Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02506244 · ClinicalTrials.gov registry record · NA
mHealth Screening to Prevent Strokes
A NA study, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- NA
- Development phase
- 6,135
- Enrollment target
NCT02506244: Completed NA study, sponsored by Scripps Translational Science Institute.
NCT02506244 is a NA study that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 6,135 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (337% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02506244, a NA study, has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,135 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether it is possible to identify a high-risk cohort suitable for screening for asymptomatic atrial fibrillation using claims data, and then engage those individuals in a mobile health technology-enabled home monitoring program in order to document previously undiagnosed atrial fibrillation, and provide clinical evidence of an outcomes benefit associated with this early detection.
Primary Outcome
Incidence of newly diagnosed AF as defined by at least 30 seconds of AF or atrial flutter at the end of the 4 month monitoring period compared to the delayed monitoring cohort (primary) and observational control (secondary)
Interventions
- DEVICE iRhythm ZIO XT Patch
- DEVICE Wristband by Amiigo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,135 participants |
| Start Date | 2015-11 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT02506244 record still lists
NCT02506244 is an interventional study that assigns participants to a tested intervention. Its 6,135 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (337% higher).
The record links to 0 conditions, and to 2 interventions - of which iRhythm ZIO XT Patch is the first listed.
NCT02506244 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02506244 about?
NCT02506244 is a clinical study titled "mHealth Screening to Prevent Strokes". The purpose of this study is to investigate whether it is possible to identify a high-risk cohort suitable for screening for asymptomatic atrial fibrillation using claims data, and then engage those individuals in a mobile health technology-enabled home monitoring program in order to document previo...
What is the current status of trial NCT02506244?
This trial is currently completed. It is a NA study. The enrollment target is 6,135 participants. The study started on 2015-11. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT02506244?
The interventions under investigation include: iRhythm ZIO XT Patch (DEVICE), Wristband by Amiigo (DEVICE).
Who is sponsoring clinical trial NCT02506244?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02506244's enrollment target sits among peer trials
6,135 22nd of 2000 higher than 1,979 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04774159 · 6,150 participants · Phase 3
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- NCT06304168 · 6,150 participants
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
- NCT07166861 · 6,080 participants · NA
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
- NCT07049861 · 6,200 participants · NA
Advancing Biopsychosocial Care Training Initiative
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia